Clinical Trial Update: Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

View source ↗

Summary

This update provides the current status of a Dupixent (dupilumab) trial for atopic dermatitis, noting that the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Dermatitis, Atopic | Status: ACTIVE_NOT_RECRUITING